# FDA Inspection 1182162 - Patrick M. Dillon, MD - October 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/patrick-m-dillon-md/9df67c31-0a14-4fe4-9ed0-d7db88b043d9
Source feed: FDA_Inspections

> FDA Inspection 1182162 for Patrick M. Dillon, MD on October 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182162
- Company Name: Patrick M. Dillon, MD
- Inspection Date: 2022-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/patrick-m-dillon-md/96acab22-4117-4f89-adfd-17bb7e3b800b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c